These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32452702)
21. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Kalsi V; Apostolidis A; Popat R; Gonzales G; Fowler CJ; Dasgupta P Eur Urol; 2006 Mar; 49(3):528-35. PubMed ID: 16426735 [TBL] [Abstract][Full Text] [Related]
22. Urodynamics in patients with multiple sclerosis: is it necessary? A randomized-controlled trial. El Helou E; Sarkis J; Mjaess G; Zalaket J; Mouawad C; Sayegh N; Ghattas S; Azar C; El Helou J; Abboud H; Koussa S; Nemr E Scand J Urol; 2021 Apr; 55(2):161-168. PubMed ID: 33565359 [TBL] [Abstract][Full Text] [Related]
23. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis. Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361 [TBL] [Abstract][Full Text] [Related]
24. Lower urinary tract dysfunction in patients with multiple sclerosis. Panicker JN; Fowler CJ Handb Clin Neurol; 2015; 130():371-81. PubMed ID: 26003255 [TBL] [Abstract][Full Text] [Related]
25. [New opportunities to treat combined luts in patients with benign prostatic hyperplasia premises and advantages]. Gadzhieva ZK; Kazilov YB Urologiia; 2017 Apr; (1):95-102. PubMed ID: 28394531 [TBL] [Abstract][Full Text] [Related]
26. Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis. Khavari R; Karmonik C; Shy M; Fletcher S; Boone T J Urol; 2017 Feb; 197(2):438-444. PubMed ID: 27664581 [TBL] [Abstract][Full Text] [Related]
27. Clinical and video urodynamic characteristics of adult women with dysfunctional voiding. Chen YC; Kuo HC J Formos Med Assoc; 2014 Mar; 113(3):161-5. PubMed ID: 24630033 [TBL] [Abstract][Full Text] [Related]
28. OnabotulinumtoxinA and multiple sclerosis. Schurch B; Carda S Ann Phys Rehabil Med; 2014 Jul; 57(5):302-314. PubMed ID: 24953702 [TBL] [Abstract][Full Text] [Related]
29. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. Ginsberg D; Gousse A; Keppenne V; Sievert KD; Thompson C; Lam W; Brin MF; Jenkins B; Haag-Molkenteller C J Urol; 2012 Jun; 187(6):2131-9. PubMed ID: 22503020 [TBL] [Abstract][Full Text] [Related]
30. Lower urinary tract symptoms in children and adolescents with Williams-Beuren syndrome. Sammour ZM; de Bessa J; Hisano M; Bruschini H; Kim CA; Srougi M; Gomes CM J Pediatr Urol; 2017 Apr; 13(2):203.e1-203.e6. PubMed ID: 27876405 [TBL] [Abstract][Full Text] [Related]
31. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report. Çetinel B; Tarcan T; Demirkesen O; Özyurt C; Şen İ; Erdoğan S; Siva A Neurourol Urodyn; 2013 Nov; 32(8):1047-57. PubMed ID: 23757108 [TBL] [Abstract][Full Text] [Related]
32. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review. Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612 [TBL] [Abstract][Full Text] [Related]
33. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Sakakibara R; Panicker J; Finazzi-Agro E; Iacovelli V; Bruschini H; Neurourol Urodyn; 2016 Jun; 35(5):551-63. PubMed ID: 25810035 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of targeted treatment for vesicoureteral reflux in children with nonneurogenic lower urinary tract dysfunction. Fast AM; Nees SN; Van Batavia JP; Combs AJ; Glassberg KI J Urol; 2013 Sep; 190(3):1028-32. PubMed ID: 23473909 [TBL] [Abstract][Full Text] [Related]
35. Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study. Zecca C; Digesu GA; Robshaw P; Singh A; Elneil S; Gobbi C J Urol; 2014 Mar; 191(3):697-702. PubMed ID: 24076308 [TBL] [Abstract][Full Text] [Related]
36. Sacral neuromodulation in patients with multiple sclerosis. Minardi D; Muzzonigro G World J Urol; 2012 Feb; 30(1):123-8. PubMed ID: 21400258 [TBL] [Abstract][Full Text] [Related]
37. Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder. Verheggen BG; Lee R; Lieuw On MM; Treur MJ; Botteman MF; Kaplan SA; Trocio JN J Med Econ; 2012; 15(3):586-600. PubMed ID: 22332704 [TBL] [Abstract][Full Text] [Related]
38. Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis. Zecca C; Panicari L; Disanto G; Maino P; Singh A; Digesu GA; Gobbi C Int Urogynecol J; 2016 Apr; 27(4):521-7. PubMed ID: 26245726 [TBL] [Abstract][Full Text] [Related]
39. Voiding dysfunction in patients with neuromyelitis optica spectrum disorders. de Carvalho FL; Gomes CM; Apostolos-Pereira SL; Bessa J; Pinheiro M; Marchiori PE; Bruschini H; Srougi M; Callegaro D Neurourol Urodyn; 2016 Jan; 35(1):39-43. PubMed ID: 25212666 [TBL] [Abstract][Full Text] [Related]
40. [Management of neuropathic bladder in multiple sclerosis]. Pappalardo A; Patti F; Reggio A Clin Ter; 2004 May; 155(5):183-6. PubMed ID: 15344566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]